01 Evolution of Dedicated Venous Stent TechnologiesThe chronic venous occlusions treatment market analysis shows that medical device developers are advancing dedicated venous stent technologies designed specifically for venous anatomy and chronic obstruction treatment. This encourages manufacturers to develop flexible stent designs that accommodate vein movement, support vessel patency, and improve the treatment of complex venous lesions. Companies such as Boston Scientific have developed dedicated venous stent systems, including the VICI Venous Stent, for treating iliofemoral venous obstructions.
02 Integration of Intravascular Ultrasound in Venous InterventionsInfluence of intravascular ultrasound (IVUS) is changing how clinicians assess venous obstructions and guide endovascular procedures. This transition is encouraging the use of real-time intravascular imaging to evaluate vessel dimensions, identify the extent of obstruction, and guide venous stent placement more accurately.Impact of Supply Chain Disruption on Chronic Venous Occlusions Treatment MarketSupply chain disruptions are expected to have a moderate impact on the chronic venous occlusions treatment market share due to dependence on medical devices, vascular stents, and specialized medical components. The market is likely to follow an S-shaped recovery, with gradual restoration of medical device supplies and manufacturing operations. Supply chain constraints could reduce market growth by 1.0–1.5 percentage points, lowering the projected CAGR of 6.25% to around 4.75%–5.25%. As supply conditions normalize, the chronic venous occlusions treatment market growth is expected to stabilize.Chronic Venous Occlusions Treatment Market Investment and Funding AnalysisThe chronic venous occlusions treatment market forecasts strategic investment activity driven by the development of minimally invasive thrombectomy systems and advancements in venous stent technologies. In February 2026, SonoVascular completed the first close of a USD 6 million Series A financing led by Harbright Ventures to support regulatory and clinical milestones for its ultrasound-assisted SonoThrombectomy System, which removes blood clots associated with conditions such as deep vein thrombosis.
01 High Incidence of Post-Thrombotic Iliac Vein Obstruction and Treatment Needs for May-Thurner Syndrome Drive MarketOccurrence of chronic iliac vein obstruction following deep vein thrombosis is creating demand for treatments that restore venous blood flow and relieve persistent symptoms. Post-thrombotic scarring and narrowing lead to leg swelling, venous hypertension, pain, and post-thrombotic syndrome, particularly among patients with extensive iliofemoral thrombosis. May-Thurner syndrome, a condition involving compression of the left common iliac vein, is creating a specific need for treatments that address chronic venous outflow obstruction. Angioplasty and venous stenting are supporting demand for chronic venous occlusion treatments by helping restore blood flow in suitable cases.